Header Logo

Connection

David Bennett to Genotype

Back to Details
This is a "connection" page, showing publications David Bennett has written about Genotype.
David Bennett
Connection Strength
4.080
Genotype
  1. Inhibitory Fc? Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease. J Alzheimers Dis. 2021; 84(3):965-968.
    View in: PubMed
    Score: 0.674
  2. Extending Alzheimer disease biomarker studies into the Hispanic community. Neurology. 2020 10 13; 95(15):665-666.
    View in: PubMed
    Score: 0.164
  3. Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):327-330.
    View in: PubMed
    Score: 0.154
  4. Using Transcriptomic Hidden Variables to Infer Context-Specific Genotype Effects in the Brain. Am J Hum Genet. 2019 09 05; 105(3):562-572.
    View in: PubMed
    Score: 0.153
  5. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement. 2019 02; 15(2):258-266.
    View in: PubMed
    Score: 0.144
  6. APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018 06 12; 90(24):e2127-e2134.
    View in: PubMed
    Score: 0.140
  7. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement. 2017 Dec; 13(12):1380-1388.
    View in: PubMed
    Score: 0.132
  8. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.103
  9. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013 Sep 01; 70(9):1150-7.
    View in: PubMed
    Score: 0.101
  10. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.099
  11. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology. 2012 May 08; 78(19):1464-71.
    View in: PubMed
    Score: 0.092
  12. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis. 2011; 23(2):249-55.
    View in: PubMed
    Score: 0.084
  13. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.075
  14. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006 Dec; 63(12):1763-9.
    View in: PubMed
    Score: 0.063
  15. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2006; 26(1):30-6.
    View in: PubMed
    Score: 0.059
  16. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.057
  17. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005 Feb; 11(1):3-7.
    View in: PubMed
    Score: 0.056
  18. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults. JAMA Neurol. 2023 09 01; 80(9):929-939.
    View in: PubMed
    Score: 0.051
  19. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry. 2002 Dec; 73(6):672-7.
    View in: PubMed
    Score: 0.048
  20. RNASE6 is a novel modifier of APOE-e4 effects on cognition. Neurobiol Aging. 2022 10; 118:66-76.
    View in: PubMed
    Score: 0.047
  21. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. Alzheimers Res Ther. 2022 02 09; 14(1):30.
    View in: PubMed
    Score: 0.045
  22. The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery. Alzheimers Dement. 2022 10; 18(10):1889-1897.
    View in: PubMed
    Score: 0.045
  23. Epigenomic features related to microglia are associated with attenuated effect of APOE e4 on Alzheimer's disease risk in humans. Alzheimers Dement. 2022 04; 18(4):688-699.
    View in: PubMed
    Score: 0.044
  24. Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE e2 protective effect in Alzheimer disease. Mol Psychiatry. 2021 10; 26(10):6054-6064.
    View in: PubMed
    Score: 0.044
  25. TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks. Alzheimers Dement. 2021 08; 17(8):1287-1296.
    View in: PubMed
    Score: 0.042
  26. Genetic control of the human brain proteome. Am J Hum Genet. 2021 03 04; 108(3):400-410.
    View in: PubMed
    Score: 0.042
  27. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain. 2020 08 01; 143(8):2561-2575.
    View in: PubMed
    Score: 0.041
  28. Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. Brain. 2020 07 01; 143(7):2272-2280.
    View in: PubMed
    Score: 0.041
  29. Sex and APOE e4 genotype modify the Alzheimer's disease serum metabolome. Nat Commun. 2020 03 02; 11(1):1148.
    View in: PubMed
    Score: 0.040
  30. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 02 03; 11(1):667.
    View in: PubMed
    Score: 0.040
  31. APOE e4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease. Neurobiol Aging. 2020 03; 87:18-25.
    View in: PubMed
    Score: 0.039
  32. A genome-wide association study identifies genetic loci associated with specific lobar brain volumes. Commun Biol. 2019; 2:285.
    View in: PubMed
    Score: 0.038
  33. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.037
  34. Genetic data and cognitively defined late-onset Alzheimer's disease subgroups. Mol Psychiatry. 2020 11; 25(11):2942-2951.
    View in: PubMed
    Score: 0.036
  35. Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly. PLoS One. 2018; 13(11):e0206803.
    View in: PubMed
    Score: 0.036
  36. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.036
  37. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018 07 24; 13(1):38.
    View in: PubMed
    Score: 0.036
  38. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.035
  39. A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Sci Transl Med. 2017 Dec 20; 9(421).
    View in: PubMed
    Score: 0.034
  40. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384.
    View in: PubMed
    Score: 0.033
  41. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017 04; 14(4):e1002287.
    View in: PubMed
    Score: 0.033
  42. Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
    View in: PubMed
    Score: 0.032
  43. Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans. Mol Neurobiol. 2017 Dec; 54(10):8021-8032.
    View in: PubMed
    Score: 0.032
  44. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults. PLoS One. 2016; 11(7):e0157452.
    View in: PubMed
    Score: 0.031
  45. Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults. Medicine (Baltimore). 2015 Nov; 94(47):e1892.
    View in: PubMed
    Score: 0.029
  46. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.029
  47. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain. 2015 Oct; 138(Pt 10):3076-88.
    View in: PubMed
    Score: 0.029
  48. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement. 2016 Mar; 12(3):233-43.
    View in: PubMed
    Score: 0.029
  49. Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimers Dement. 2015 Dec; 11(12):1439-1451.
    View in: PubMed
    Score: 0.029
  50. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16.
    View in: PubMed
    Score: 0.028
  51. Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium. Biol Psychiatry. 2015 Apr 15; 77(8):749-63.
    View in: PubMed
    Score: 0.028
  52. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
    View in: PubMed
    Score: 0.027
  53. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimers Dement. 2014 Nov; 10(6):609-618.e11.
    View in: PubMed
    Score: 0.027
  54. Genetic susceptibility for ischemic infarction and arteriolosclerosis based on neuropathologic evaluations. Cerebrovasc Dis. 2013; 36(3):181-188.
    View in: PubMed
    Score: 0.026
  55. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.025
  56. Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2013 Oct; 162B(7):770-8.
    View in: PubMed
    Score: 0.025
  57. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ?4,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013 Apr 10; 309(14):1483-92.
    View in: PubMed
    Score: 0.025
  58. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.
    View in: PubMed
    Score: 0.025
  59. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10(1):45-52.
    View in: PubMed
    Score: 0.025
  60. A common polymorphism near PER1 and the timing of human behavioral rhythms. Ann Neurol. 2012 Sep; 72(3):324-34.
    View in: PubMed
    Score: 0.024
  61. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8.
    View in: PubMed
    Score: 0.023
  62. A coding variant in CR1 interacts with APOE-e4 to influence cognitive decline. Hum Mol Genet. 2012 May 15; 21(10):2377-88.
    View in: PubMed
    Score: 0.023
  63. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012 Jan 31; 78(5):334-41.
    View in: PubMed
    Score: 0.023
  64. A genome-wide association study of aging. Neurobiol Aging. 2011 Nov; 32(11):2109.e15-28.
    View in: PubMed
    Score: 0.022
  65. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.021
  66. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010 Dec; 67(12):1473-84.
    View in: PubMed
    Score: 0.020
  67. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010 Aug 15; 19(16):3295-301.
    View in: PubMed
    Score: 0.020
  68. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42(3):234-9.
    View in: PubMed
    Score: 0.020
  69. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 05; 134B(1):1-5.
    View in: PubMed
    Score: 0.014
  70. Genetic association of low density lipoprotein receptor and Alzheimer's disease. Neurobiol Aging. 2005 Jan; 26(1):1-7.
    View in: PubMed
    Score: 0.014
  71. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.011
  72. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000 Nov 06; 427(1):19-30.
    View in: PubMed
    Score: 0.010
  73. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999 Aug; 158(2):469-90.
    View in: PubMed
    Score: 0.010
  74. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997 Mar 12; 277(10):822-4.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.